Floatz logo

Trimetazidine

Peripheral Neuropathy Due to Chemotherapy

Minia UniversitySmall moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

29 Active assets in the Peripheral Neuropathy Due to Chemotherapy cohort.

Asset / SponsorPhaseRating
Pregabalin
University of Rochester
Phase 4BB
LIDOCAINE
Hospital Ambroise Paré Paris
Phase 2BB
Omeprazole
Aya Mohamed Sadek Elsaid
Phase 3BB
Mecobalamin
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2/3B
Vitamin B6
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2/3B

View all 46 →

Same molecule, other indications

Trimetazidine is also rated in:

Transthyretin Amyloid CardiopathyDormant
BB
Indicative ·
69 / 100
View asset →
mitochondrial diseaseDormant
BB
Indicative ·
69 / 100
View asset →
hepatocellular carcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →